Susquehanna Fundamental Investments, LLC Ascendis Pharma A/S Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $1.47 Million - $2.05 Million	-11,807 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$151.2 - $182.76 $711,698 - $860,251	4,707 Added 66.3%	11,807 $1.97 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $953,459 - $1.1 Million	7,100 New	7,100 $1.1 Million

228

56.6M

142K

259K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.22B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.